Compounding Pharmacies and GLP-1: How It Works and Why It Matters

If you've looked into GLP-1 medications for weight loss and seen prices of $249/month instead of $1,000+, you've encountered compounding. Understanding what compounding actually is — how it works legally, how quality is maintained, and what the real risks are — is essential context for any informed decision about GLP-1 access.

What Pharmaceutical Compounding Is

Compounding is the preparation of a customized medication by a licensed pharmacy for a specific patient. It's not new — compounding has existed as long as pharmacy has. Before mass pharmaceutical manufacturing, every prescription was compounded.

Today, compounding fills specific gaps: - A medication is commercially unavailable or on shortage - A patient needs a dose not commercially available - A patient needs a specific formulation (no dye, different route of administration) - Cost makes the commercial version inaccessible

The GLP-1 case primarily involves shortage-based compounding. When brand-name semaglutide (Ozempic/Wegovy) was on the FDA's drug shortage list, federal law (Section 503A of the FD&C Act) explicitly permitted state-licensed compounding pharmacies to compound versions of that drug to help fill the supply gap.

The Two Types of Compounding Pharmacies

503A pharmacies are traditional patient-specific compounders. They prepare medications in response to individual prescriptions from licensed prescribers. Regulated by state pharmacy boards. Each compound is made for a specific patient.

503B outsourcing facilities operate at scale — more like small manufacturers. They're federally registered with the FDA, subject to cGMP (Current Good Manufacturing Practice) standards similar to pharmaceutical companies, and can produce larger quantities. More rigorous oversight, typically better standardized quality control.

When evaluating a telehealth platform, ask which type of pharmacy they use. 503B facilities generally offer stronger quality assurance.

What's Actually in Compounded Semaglutide

Compounded semaglutide contains semaglutide (the same active pharmaceutical ingredient used in Ozempic and Wegovy), typically formulated as a sterile injectable solution in a multidose vial. Inactive ingredients may include bacteriostatic water, sodium phosphate, and pH adjusters.

Some compounders add other ingredients — B12, L-carnitine, or others — in combination formulas. These can be prescribed, but aren't the same as pure semaglutide, and their clinical evidence is thinner. Know what you're getting.

The Shortage Situation and Legal Status

The FDA declared semaglutide no longer in shortage in early 2025. This had significant regulatory implications: shortage-based compounding is permitted specifically when the commercial drug is in shortage. When it's not, the legal basis for widespread compounding shrinks.

The FDA pursued enforcement action against compounders after the shortage declaration, resulting in many large-scale compounders halting semaglutide production. As of early 2026, compounded semaglutide is still available through some 503A pharmacies for individual patients with valid prescriptions, but the market has contracted from its peak.

Tirzepatide (Zepbound/Mounjaro) has had its own shortage status fluctuations — check current FDA shortage list status, as this changes.

What this means for you: Compounded GLP-1 availability has changed and continues to shift. Work with a telehealth platform that stays current on regulatory status and can be transparent about what they're prescribing and from where.

How to Evaluate a Compounding Pharmacy's Quality

Ask for Certificate of Analysis (CoA). Reputable compounders test each batch and can provide a CoA showing the active ingredient concentration, sterility testing results, and other quality metrics. If a pharmacy can't produce a CoA, that's a concern.

Verify the pharmacy's license. State pharmacy licenses are public record. Confirm the pharmacy is licensed in your state. For 503B facilities, the FDA maintains a list of registered outsourcing facilities.

Ask about testing. Is the active ingredient USP-grade? Is each batch tested for potency and sterility? What are the storage requirements and expiration dating?

Understand the supply chain. Where does the active pharmaceutical ingredient come from? Established US-licensed API suppliers are preferable to unclear overseas sources.

Why the Price Difference Is So Large

Brand-name Ozempic at $1,000+/month reflects Novo Nordisk's R&D costs, FDA approval process, marketing spend, and profit margin. The active ingredient itself (the semaglutide molecule) is not $1,000 worth of chemical — it's a peptide that costs substantially less to manufacture at the API level.

Compounders buy API from licensed suppliers, mix it in their pharmacies, and dispense it without the brand manufacturer's overhead layer. The cost differential is real and the compound contains the same active ingredient.

The Honest Risks

Variable quality. Not all compounders are equal. Without brand-manufacturer standardization and FDA drug approval oversight, quality depends on the specific pharmacy's practices. Due diligence matters.

Regulatory uncertainty. The legal landscape has shifted and continues to shift. A compounding option available today may not be available in six months. Be prepared for that reality.

Salt forms. Some early reports surfaced about certain compounders using semaglutide sodium or acetate salt forms rather than the base semaglutide used in FDA-approved drugs. These have different bioavailability profiles and aren't the same as branded semaglutide. Ask specifically what form of semaglutide your compound uses.

No FDA review of the specific formulation. Compounded drugs don't go through FDA's drug approval process. The active ingredient may be the same, but the specific formulation hasn't been reviewed the way Ozempic was.

The Bottom Line

Compounding is a legitimate and legal way to access GLP-1 medications at significantly lower cost — when done through a reputable pharmacy with proper oversight, using quality-tested API, and with a valid prescription from a licensed physician.

The key questions: Who's the pharmacy? Can they produce a CoA? Are they 503A or 503B? What form of semaglutide are they using? What does the telehealth platform know about their pharmacy partners?

Marrow works with licensed compounding pharmacies and can answer these questions directly. If you have questions about sourcing before starting your intake, [reach out here](/start).